Guimaraes, A.G.; Scotti, L.; Scotti, M.T.; Mendonca, F.J.B.; Melo, N.S.R.; Alves, R.S.; De Lucca, W.; Bezerra, D.P.; Gelain, D.P.; Quintans, L.J. Evidence for the involvement of descending pain-inhibitory mechanisms in the attenuation of cancer pain by carvacrol aided through a docking study. Life Sciences., 2014, 116(1), 8-15.

Scotti, L.; Ishiki, H.; Mendonca, F.J.B.; Santos, P.F.; Tavares, J.F.; Silva, M.S.; Scotti, M.T. Theoretical Research into Anticancer Activity of Diterpenes Isolated from the Paraiban Flora. Nat. Prod. Comm., 2014, 9(7), 911-914.

Scotti, L.; Scotti, M.T.; Ishiki, H.; Junior, F.; dos Santos, P.F.; Tavares, J.F.; da Silva, M.S. Prediction of Anticancer Activity of Diterpenes Isolated from the Paraiban Flora through a PLS Model and Molecular Surfaces. Nat. Prod. Comm., 2014, 9(5), 609-612.

Scotti, L.; Mendonca, F.J.B.; Moreira, D.R.M.; da Silva, M.S.; Pitta, I.R.; Scotti, M.T. SAR, QSAR and Docking of Anticancer Flavonoids and Variants: A Review. Curr. Top. Med. Chem., 2012, 12(24), 2785-2809.

Tavares, F.M.; Gomes, A.C.; Assunção, E.M.; Medeiros, J.L.S.; Scotti, M.T.; Scotti, L.; Ishiki, H.M. Virtual screening and molecular docking: discovering novel c-KIT inhibitors. Curr. Med. Chem., 2022, 29(2), 166-188.
[http://dx.doi.org/10.2174/0929867328666210915102920] [PMID: 34525909]

Silva, L.R.; Silva-Júnior, E.F. Inhibiting the “Undruggable” RAS/farnesyltransferase (FTase) cancer target by manumycin-related natural products. Curr. Med. Chem., 2022, 29(2), 189-211.
[http://dx.doi.org/10.2174/0929867328666210315123848 ] [PMID: 33719954]

Nandi, S.; Dey, R.; Samadder, A.; Saxena, A.; Saxena, A.K. Natural sourced inhibitors of EGFR, PDGFR, FGFR and VEGFR-mediated signaling pathways as potential anticancer agents. Curr. Med. Chem., 2022, 29(2), 212-234.
[http://dx.doi.org/10.2174/0929867328666210303101345] [PMID: 33655823]